Ventilator-associated pneumonia: caveats for benchmarking

Intensive Care Med. 2003 Nov;29(11):2086-9. doi: 10.1007/s00134-003-1991-9. Epub 2003 Sep 3.

Abstract

Objective: To determine the influence of using different denominators on risk estimates of ventilator-associated pneumonia (VAP).

Design and setting: Prospective cohort study in the medical ICU of a large teaching hospital.

Patients: All consecutive patients admitted for more than 48 h between October 1995 and November 1997.

Measurements and results: We recorded all ICU-acquired infections using modified CDC criteria. VAP rates were reported per 1,000 patient-days, patient-days at risk, ventilator-days, and ventilator-days at risk. Of the 1,068 patients admitted, VAP developed in 106 (23.5%) of those mechanically ventilated. The incidence of the first episode of VAP was 22.8 per 1,000 patient-days (95% CI 18.7-27.6), 29.6 per 1,000 patient-days at risk (24.2-35.8), 35.7 per 1,000 ventilator-days (29.2-43.2), and 44.0 per 1,000 ventilator-days at risk (36.0-53.2). When considering all episodes of VAP (n=127), infection rates were 27.3 episodes per 1,000 ICU patient-days (95% CI 22.6-32.1) and 42.8 episodes per 1,000 ventilator-days (35.3-50.2).

Conclusions: The method of reporting VAP rates has a significant impact on risk estimates. Accordingly, clinicians and hospital management in charge of patient-care policies should be aware of how to read and compare nosocomial infection rates.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Benchmarking*
  • Critical Care / methods
  • Critical Care / standards
  • Cross Infection / diagnosis
  • Cross Infection / epidemiology*
  • Cross Infection / etiology
  • Cross Infection / prevention & control
  • Female
  • Hospital Mortality
  • Hospitals, University
  • Humans
  • Incidence
  • Infection Control / methods
  • Infection Control / standards
  • Intensive Care Units
  • Length of Stay / statistics & numerical data
  • Male
  • Middle Aged
  • Pneumonia / diagnosis
  • Pneumonia / epidemiology*
  • Pneumonia / etiology
  • Pneumonia / prevention & control
  • Prospective Studies
  • Respiration, Artificial / adverse effects*
  • Risk Assessment
  • Risk Factors
  • Switzerland / epidemiology
  • Time Factors